U.S. Venture Partners

HeartFlow Inc., established in 2007 and headquartered in Redwood City, California, specializes in non-invasive coronary artery detection solutions. The company's flagship product, HeartFlow Analysis, employs artificial intelligence to generate a personalized 3D model of the heart using standard CT scan data. This enables clinicians worldwide to assess the impact of blockages on blood flow and determine optimal patient treatment, thereby reducing unnecessary invasive testing. HeartFlow operates additional offices in Portland (Oregon), Austin (Texas), London (UK), and Tokyo (Japan).

MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating various neurological diseases. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation (VNS) to address conditions such as tinnitus, chronic pain, and rehabilitation for stroke survivors. Its notable products include the Serenity System, designed specifically for tinnitus treatment, and the Vivistim device, which is FDA approved for assisting ischemic stroke survivors with moderate to severe upper limb impairment. Through its innovative approaches, MicroTransponder aims to enhance recovery and improve the quality of life for individuals affected by these neurological conditions.

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.

Nervonik is a medical device company that specializes in developing an opioid-free peripheral nerve stimulation (PNS) system for therapeutic applications. The company focuses on creating a neuro-modulation device that is miniaturized and incorporates sensing feedback to deliver closed-loop optimized therapy. This innovative approach aims to provide effective treatment for patients suffering from chronic disorders. Nervonik is dedicated to advancing clinical research and achieving regulatory milestones to bring its cutting-edge therapies to market.

Delfina operates a data-driven prenatal care system designed to enhance maternal and infant safety during pregnancy. The company employs machine learning models to optimize interventional workflows and create personalized care plans based on patient risk factors, thereby facilitating early interventions and improving provider efficiency. This approach aims to deliver equitable and cost-effective pregnancy care within the healthcare industry.

Quantifind, Inc. is a data science company that specializes in developing advanced analytical platforms aimed at enhancing decision-making in various sectors. Founded in 2009 and headquartered in Menlo Park, California, the company offers a suite of tools including signum Analysis, signum Voice, and signum Impact. These tools facilitate insights into brand performance, revenue drivers, and the effectiveness of sponsorships across multiple industries such as automotive, consumer packaged goods, entertainment, financial services, pharmaceuticals, retail, and telecommunications. Additionally, Quantifind provides AI-driven solutions for anti-money laundering and fraud detection, which integrate internal financial data with public domain information to identify risks and streamline compliance efforts. The company's innovative approach aids organizations and law enforcement in mitigating financial crimes, thus enhancing overall security and operational efficiency. Quantifind also maintains a strategic partnership with Oracle Financial Services to further bolster its offerings.

Lightlytics specializes in cloud deployment technologies that assist SRE and DevOps teams in managing infrastructure updates and developments. The company provides a continuously updated model of cloud environments by tracking behavior and configuration changes. Its technology enables teams to automatically predict, pre-empt, and prevent potential failures, downtime, and business disruptions by simulating all possible dependencies and assessing their impact on operations prior to deployment. This capability allows organizations to code and deploy configurations efficiently and securely, ensuring smooth operations from code to cloud.

Okami Medical, Inc. is a medical device manufacturer based in Aliso Viejo, California, specializing in the occlusion of peripheral vessels to treat cardiovascular disease. The company's flagship product, the LOw-profile Braided Occluder (LOBO), is designed to provide interventional physicians with a single, versatile device for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011, Okami Medical aims to meet the evolving needs of patients and healthcare providers by offering innovative solutions that ensure rapid and reliable vessel occlusion, regardless of anatomical challenges.

ShiraTronics, Inc. is a company focused on developing and commercializing innovative therapies for the treatment of chronic migraines. Incorporated in 2018 and headquartered in Ireland, with an additional location in Minneapolis, Minnesota, ShiraTronics utilizes advanced neuromodulation technology to address the unmet clinical needs of patients suffering from debilitating migraine headaches. The company's mission is to transform the lives of those affected by this widespread and disabling disorder, which impacts millions globally, by providing effective solutions that enhance their quality of life.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

Sepio is a developer of an asset risk management platform focused on protecting organizations from hardware-based attacks. The company's innovative solution operates on asset existence rather than activity, utilizing physical layer asset DNA profiling to deliver actionable visibility and policy enforcement. This platform enables security teams to gain comprehensive insights into their hardware assets and monitor their behavior in real-time. With the ability to define granular device usage rules, Sepio allows administrators to continuously oversee and safeguard their infrastructure. The solution is asset agnostic, accommodating various environments including IT, OT, and IoT, and can report on existing assets and their associated risk factors within 24 hours. Ultimately, Sepio aims to enhance clients' cybersecurity posture by providing robust control over hardware assets and mitigating the risks posed by rogue devices.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for disorders associated with corticosteroid excess, including hypercortisolism and conditions resulting from long-term corticosteroid usage. Founded in 2013 by David A. Katz and headquartered in Portland, Oregon, the company aims to improve patient outcomes by offering targeted therapies that address the underlying causes of corticosteroid-related disorders. Its lead product, SPI-62, is an oral small molecule designed to target active intracellular corticosteroids in key tissues, representing a novel approach in the management of these serious health issues. By leveraging scientific insights into corticosteroid biology, Sparrow Pharmaceuticals seeks to revolutionize the treatment landscape for autoimmune and inflammatory conditions.

Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

Cagent Vascular, LLC is a medical device company that specializes in developing innovative angioplasty balloons utilizing proprietary serration technology. Incorporated in 2014 and based in Wayne, Pennsylvania, the company has created the Serranator, a unique angioplasty device featuring serrated metal strips embedded in a semi-compliant balloon. This device is designed to treat atherosclerosis by effectively addressing blocked arteries, particularly in patients with peripheral artery disease and chronic limb-threatening ischemia. Cagent Vascular's technology aims to enhance the effectiveness of vessel dilatation procedures in cardiovascular interventions, providing healthcare providers with advanced tools to improve patient outcomes.

IONIX is a security solutions provider specializing in attack surface management through its innovative platform, which leverages Connective Intelligence to identify and mitigate exploitable risks across both digital and internet-facing assets. The company's technology employs machine learning to discover and monitor organizational assets, analyze their connections, and assess risks with a contextual approach. By utilizing inside-out and reverse detection techniques, IONIX helps organizations uncover new vulnerabilities and respond to risky changes effectively. Its comprehensive suite of tools facilitates the prioritization of critical threats and supports end-to-end remediation workflows. Esteemed global companies, such as Infosys and Warner Music Group, rely on IONIX to enhance their security posture and proactively manage their complex attack surfaces in an ever-evolving threat landscape.

Zero Networks Inc. is a network security software developer founded in 2019 and headquartered in Tel Aviv, Israel. The company specializes in automating the definition, enforcement, and adaptation of network access policies for users and machines within an organization. Its cloud-based technology customizes access controls by learning how users and devices communicate, thereby enhancing security without the need for agents or complex policy configurations. Additionally, Zero Networks incorporates a two-factor authentication mechanism that allows legitimate but unusual connections through a secure wall on mobile devices. This approach ensures robust protection against potential breaches while maintaining operational continuity, making it an effective solution for organizations seeking to strengthen their network security posture.

Stensul is an innovative company focused on transforming email marketing for enterprise-level organizations. Its email generation platform is designed to streamline the email creation process by centralizing and pre-configuring templates to align with each brand's specific requirements. By eliminating the need for extensive collaboration with designers, developers, and quality assurance teams, Stensul allows marketers to concentrate on creating impactful content that drives results. The platform simplifies complex coding and design tasks, enabling marketing teams to produce mobile-responsive emails that adhere to brand, design, and legal standards. As a result, enterprises can efficiently generate effective emails while significantly reducing production time and costs.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

Darwinium is a technology company that specializes in a decision technology platform aimed at enhancing security, combating fraud, and improving customer experience. The platform employs integrated machine learning, orchestration, and analytics to protect mobile applications, websites, and APIs from sophisticated automated attacks. By focusing on customer privacy and minimizing risk exposure, Darwinium implements techniques such as anonymization, masking, and secure computing. This comprehensive approach enables clients to increase revenues, reduce fraud losses, and effectively block bot activity, thereby creating a safer digital environment for users.

Luminopia is a company focused on developing innovative treatments for significant neuro-visual disorders, particularly amblyopia, commonly known as lazy eye, which is a leading cause of vision loss in children. By creating engaging digital therapeutics, Luminopia aims to provide effective solutions that are rigorously evaluated for FDA approval. Their flagship product, Luminopia One, leverages binocular vision techniques to address amblyopia, enabling healthcare professionals to offer new treatment options for affected patients. Partnering with Boston Children’s Hospital, Luminopia is at the forefront of pioneering advanced therapeutic approaches that enhance patient care in the field of pediatric vision health.

Trust Lab develops software for social media platforms that helps in detecting misinformation, hate speech, and harmful content.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Surgical Safety Technologies is a company focused on enhancing the safety and efficiency of healthcare through its AI-driven medical technology platform. The company provides hospitals with data-driven solutions that empower surgeons by offering an objective assessment of both technical and non-technical skills based on academically validated frameworks. Its platform generates descriptive, predictive, and prescriptive insights that support informed clinical and operational decision-making, ultimately aiming to improve surgical quality and patient safety.

HeartFlow Inc., established in 2007 and headquartered in Redwood City, California, specializes in non-invasive coronary artery detection solutions. The company's flagship product, HeartFlow Analysis, employs artificial intelligence to generate a personalized 3D model of the heart using standard CT scan data. This enables clinicians worldwide to assess the impact of blockages on blood flow and determine optimal patient treatment, thereby reducing unnecessary invasive testing. HeartFlow operates additional offices in Portland (Oregon), Austin (Texas), London (UK), and Tokyo (Japan).

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.

Quantifind, Inc. is a data science company that specializes in developing advanced analytical platforms aimed at enhancing decision-making in various sectors. Founded in 2009 and headquartered in Menlo Park, California, the company offers a suite of tools including signum Analysis, signum Voice, and signum Impact. These tools facilitate insights into brand performance, revenue drivers, and the effectiveness of sponsorships across multiple industries such as automotive, consumer packaged goods, entertainment, financial services, pharmaceuticals, retail, and telecommunications. Additionally, Quantifind provides AI-driven solutions for anti-money laundering and fraud detection, which integrate internal financial data with public domain information to identify risks and streamline compliance efforts. The company's innovative approach aids organizations and law enforcement in mitigating financial crimes, thus enhancing overall security and operational efficiency. Quantifind also maintains a strategic partnership with Oracle Financial Services to further bolster its offerings.

HealthJoy, LLC is a healthcare decision platform based in Chicago, Illinois, founded in 2014. The company operates a benefits experience platform designed to simplify the healthcare process for employees and improve their understanding of available benefits. By leveraging personalized guidance and artificial intelligence, HealthJoy empowers users to make informed healthcare decisions, helping them reduce out-of-pocket expenses. The platform offers a digital benefits wallet that integrates with existing employer benefits, providing on-demand access to online medical consultations, healthcare concierges, prescription savings, and more. Through its services, HealthJoy aims to create happier, more informed employees while simultaneously supporting companies in cost containment and reducing the volume of inquiries directed to HR.

Sepio is a developer of an asset risk management platform focused on protecting organizations from hardware-based attacks. The company's innovative solution operates on asset existence rather than activity, utilizing physical layer asset DNA profiling to deliver actionable visibility and policy enforcement. This platform enables security teams to gain comprehensive insights into their hardware assets and monitor their behavior in real-time. With the ability to define granular device usage rules, Sepio allows administrators to continuously oversee and safeguard their infrastructure. The solution is asset agnostic, accommodating various environments including IT, OT, and IoT, and can report on existing assets and their associated risk factors within 24 hours. Ultimately, Sepio aims to enhance clients' cybersecurity posture by providing robust control over hardware assets and mitigating the risks posed by rogue devices.

SecuriThings, Inc. specializes in providing comprehensive security solutions for Internet of Things (IoT) devices, leveraging big data and machine learning to detect cyber threats in real time. Founded in 2015 and headquartered in Tel Aviv, Israel, with an additional office in New York, the company offers a robust platform that enhances security and operational efficiency for organizations managing large fleets of IoT devices. Their Horizon platform integrates cloud-connected devices, delivering automation, analytics, and actionable alerts to ensure system availability, compliance, and cyber protection. Trusted by Fortune 100 companies, SecuriThings' solutions have been deployed in various sectors, including major airports, universities, and hospitals. Through partnerships with system integrators and device manufacturers, the company provides extensive insights and reliability in managing IoT security.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers a flexible payment structure, allowing them to rent or buy items on a monthly subscription basis with the option to try before they commit, all at 0% interest. This approach enables customers to create appealing living spaces without financial strain, making home decoration both accessible and affordable.

TaskHuman, Inc. is a digital coaching platform that connects users with a global network of wellness coaches through real-time video calls. Founded in 2017 and based in Palo Alto, California, the platform offers personalized 1-on-1 coaching across a wide range of wellness topics, including physical fitness, mental well-being, nutrition, and career development. TaskHuman aims to make self-care and personal wellness accessible and affordable, enabling individuals to discover and engage with coaches who provide guidance tailored to their specific needs. The platform covers over 1,000 aspects of well-being, ensuring that users receive comprehensive support to lead healthier lives.

MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating various neurological diseases. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation (VNS) to address conditions such as tinnitus, chronic pain, and rehabilitation for stroke survivors. Its notable products include the Serenity System, designed specifically for tinnitus treatment, and the Vivistim device, which is FDA approved for assisting ischemic stroke survivors with moderate to severe upper limb impairment. Through its innovative approaches, MicroTransponder aims to enhance recovery and improve the quality of life for individuals affected by these neurological conditions.

Nfinite is a company that specializes in developing a sophisticated CGI platform that employs artificial intelligence and 3D technology to enhance product visualization for brands and retailers. Founded in 2017 and operating in both the United States and France, Nfinite provides an innovative solution for product merchandising by enabling the creation of high-quality visual content through virtual shooting. This technology allows retailers to replace traditional photographic images with dynamic and customizable visuals, thus improving online and catalog displays. Additionally, Nfinite offers comprehensive AI training and fine-tuning services, utilizing synthetic data to optimize AI models for specific industry applications. This approach ensures enhanced performance and efficiency, positioning Nfinite as a key partner for businesses seeking to leverage AI-driven visual experiences.

Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

IONIX is a security solutions provider specializing in attack surface management through its innovative platform, which leverages Connective Intelligence to identify and mitigate exploitable risks across both digital and internet-facing assets. The company's technology employs machine learning to discover and monitor organizational assets, analyze their connections, and assess risks with a contextual approach. By utilizing inside-out and reverse detection techniques, IONIX helps organizations uncover new vulnerabilities and respond to risky changes effectively. Its comprehensive suite of tools facilitates the prioritization of critical threats and supports end-to-end remediation workflows. Esteemed global companies, such as Infosys and Warner Music Group, rely on IONIX to enhance their security posture and proactively manage their complex attack surfaces in an ever-evolving threat landscape.

Kryptowire was jumpstarted by the Defense Advanced Research Projects Agency (DARPA) and the Department of Homeland Security (DHS S&T), and has been vetted by the US military, law enforcement, and intelligence agencies. Kryptowire provides mobile application security analysis tools, anti‐piracy technologies, mobile app marketplace security analytics, and Enterprise Mobility Management (EMM) solutions. Kryptowire was founded in 2011, is based in Fairfax, Virginia, and has a customer base ranging from government agencies to national cable TV companies.

Nfinite is a company that specializes in developing a sophisticated CGI platform that employs artificial intelligence and 3D technology to enhance product visualization for brands and retailers. Founded in 2017 and operating in both the United States and France, Nfinite provides an innovative solution for product merchandising by enabling the creation of high-quality visual content through virtual shooting. This technology allows retailers to replace traditional photographic images with dynamic and customizable visuals, thus improving online and catalog displays. Additionally, Nfinite offers comprehensive AI training and fine-tuning services, utilizing synthetic data to optimize AI models for specific industry applications. This approach ensures enhanced performance and efficiency, positioning Nfinite as a key partner for businesses seeking to leverage AI-driven visual experiences.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Qnovo, established in 2010, specializes in intelligent battery management software for lithium-ion batteries used in electric vehicles, energy storage systems, and consumer devices. Headquartered in Milpitas, California, the company enhances battery performance through predictive analytics, improving health, safety, and longevity. Qnovo's technology is employed by leading automotive manufacturers and has been integrated into over 150 million smartphones worldwide. The company holds over 50 patents and is backed by prominent investors such as BorgWarner and OGCI Climate Investments.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

TaskHuman, Inc. is a digital coaching platform that connects users with a global network of wellness coaches through real-time video calls. Founded in 2017 and based in Palo Alto, California, the platform offers personalized 1-on-1 coaching across a wide range of wellness topics, including physical fitness, mental well-being, nutrition, and career development. TaskHuman aims to make self-care and personal wellness accessible and affordable, enabling individuals to discover and engage with coaches who provide guidance tailored to their specific needs. The platform covers over 1,000 aspects of well-being, ensuring that users receive comprehensive support to lead healthier lives.

Luma Health Inc. is a technology company that specializes in developing a patient engagement platform aimed at enhancing communication between healthcare providers and patients. Founded in 2015 and based in San Francisco, California, the company offers a suite of services designed to streamline various aspects of patient care, including smart scheduling, appointment reminders, mobile patient intake, and referral management. Luma Health's platform also integrates with electronic health records (EHR) and provides insights and analytics to improve healthcare delivery. By facilitating better access and communication, Luma Health enables healthcare systems and clinics to optimize appointment scheduling, enhance patient adherence to care plans, and promote continuous care, ultimately improving overall treatment outcomes.

eFFECTOR Therapeutics, Inc. is a clinical-stage biotechnology company based in San Diego, California, that specializes in the development of selective translation regulators for the treatment of cancer and other serious diseases. Founded in 2012, the company is pioneering a new class of oncology drugs known as selective translation regulator inhibitors (STRIs). These drug candidates specifically target the eIF4F complex and its associated kinase, MNK 1/2, which play critical roles in protein synthesis and are linked to prominent cancer signaling pathways such as PI3K-AKT and RAS-MEK. eFFECTOR's products aim to inhibit pathways that drive tumor growth, survival, and immune evasion by regulating the expression of oncoproteins and immunosuppressive proteins. The lead candidate, tomivosertib, is currently being evaluated in a Phase 2b trial for non-small cell lung cancer in combination with pembrolizumab. Additionally, zotatifin, an inhibitor of eIF4A, is undergoing dose-escalation in a Phase 1/2 trial, with further expansion cohorts anticipated. The company also collaborates with Pfizer to advance inhibitors targeting eIF4E.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Carrot Fertility, Inc. offers comprehensive fertility benefits services for employers, supporting employees throughout their fertility healthcare journey on a global scale. Founded in 2015 and headquartered in San Francisco, California, the company provides a range of services including egg freezing, in vitro fertilization, adoption, donor and gestational carrier services. It also features Carrot Rx, a premium pharmacy experience for fertility medications, and Carrot Pregnancy, which offers virtual access to experts and on-demand doctor-approved content. Additionally, Carrot Card is a flexible debit card that employees can use to pay for fertility care. Carrot Fertility aims to help companies customize their fertility benefits, ensuring that employees receive the necessary financial, medical, and emotional support as they pursue parenthood. The company has expanded its presence with additional offices in major cities including Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Human Interest is a retirement plan provider based in San Francisco, California, founded in 2015 by Paul Sawaya and Roger Lee. The company specializes in making it easy for small and medium-sized businesses to offer retirement savings plans to their employees. Human Interest has developed an end-to-end technology platform that addresses administrative and compliance challenges, providing affordable and straightforward employee retirement plans. This platform automatically creates employee accounts and syncs deductions with payroll providers, while also offering personalized investment advice. Through these services, Human Interest has assisted thousands of businesses across America in providing retirement accounts to their employees.

Ribon Therapeutics, Inc. is a biotechnology company founded in 2015 and headquartered in Lexington, Massachusetts. The company focuses on developing novel therapeutics that target monoPARP proteins, which are critical regulators of cancer cell survival mechanisms. By leveraging insights from its scientific founders, Ribon is establishing a proprietary drug discovery platform aimed at investigating the molecular actions and biological functions of a specific subset of the PARP protein family. This platform enables Ribon to create a pipeline of innovative small molecule inhibitors designed to disrupt the fundamental survival capabilities of cancer cells under stress. In addition to cancer treatment, the company's research may have implications for addressing other diseases. Ribon is supported by notable life science investors, which enhances its capacity to advance its therapeutic developments.

Standard Bariatrics is a medical device company based in Cincinnati, Ohio, specializing in the development of surgical instruments for weight-loss surgeries, particularly laparoscopic sleeve gastrectomy. Founded in 2014, the company has created a series of disposable surgical tools designed to work alongside general-use endoscopic staplers. These innovative tools help surgeons standardize their techniques, reduce variability, and minimize waste during procedures. By decreasing the number of cartridges needed for each surgery, Standard Bariatrics enables healthcare providers to lower costs while ensuring consistent surgical outcomes.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers a flexible payment structure, allowing them to rent or buy items on a monthly subscription basis with the option to try before they commit, all at 0% interest. This approach enables customers to create appealing living spaces without financial strain, making home decoration both accessible and affordable.

Informed, Inc., established in 2016 and headquartered in San Francisco, California, operates a platform that connects buyers and sellers of pre-owned cars while also providing solutions for banks to enhance their digital transformation. The company offers turn-key robotic process automation that performs essential verification tasks, including income, identity, residence, and insurance verification. These services help banks minimize manual costs associated with document reviews, reduce the risk of fraud, mitigate bias, and decrease errors during loan origination and account openings. Additionally, Informed's consumer auto financing platform utilizes a digital assistant and machine learning with optical character recognition to streamline the collection and analysis of loan documents, thereby facilitating automated loan origination for auto lenders.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for disorders associated with corticosteroid excess, including hypercortisolism and conditions resulting from long-term corticosteroid usage. Founded in 2013 by David A. Katz and headquartered in Portland, Oregon, the company aims to improve patient outcomes by offering targeted therapies that address the underlying causes of corticosteroid-related disorders. Its lead product, SPI-62, is an oral small molecule designed to target active intracellular corticosteroids in key tissues, representing a novel approach in the management of these serious health issues. By leveraging scientific insights into corticosteroid biology, Sparrow Pharmaceuticals seeks to revolutionize the treatment landscape for autoimmune and inflammatory conditions.

AirEye is a cybersecurity company that specializes in protecting organizations from airborne attacks targeting their network. Its flagship product, AirEye Dome, is a software-as-a-service platform that provides comprehensive visibility and control over all wireless communications, including Wi-Fi, cellular, 5G, and Bluetooth. By monitoring these channels in real-time, AirEye Dome can detect unauthorized access, block attacks, and prevent data leaks, all while seamlessly integrating with existing network security infrastructure. This platform addresses vulnerabilities posed by employee hotspots, shadow networks, and dual-connected devices, using AI-driven, agent-less technology to safeguard IT and operational technology assets. AirEye serves a diverse array of industries, such as finance, healthcare, manufacturing, retail, and aerospace, ensuring robust protection against potential threats in their corporate airspace.

Territory Foods is a meal delivery service that specializes in chef-prepared, nutritionist-approved meals tailored to meet various dietary preferences and regional tastes. Founded in 2011 and headquartered in Arlington, VA, the company offers a rotating menu of freshly made artisan meals that are responsibly sourced and free of refined sugars, gluten, and dairy. Meals are designed by in-house culinary professionals and nutrition experts, with an emphasis on customization to accommodate dietary templates such as Vegan, Vegetarian, Whole30, and Keto. Territory Foods utilizes a proprietary algorithm to provide personalized menu options at scale, allowing health-conscious consumers to enjoy convenient, ready-to-eat meals delivered to their doorstep.

Dapper Labs Inc., founded in 2018 and based in Vancouver, Canada, specializes in developing blockchain-based gaming platforms and collectibles. The company is best known for NBA Top Shot, which utilizes blockchain technology to facilitate non-fungible tokens (NFTs) and enhance digital engagement for sports fans. Dapper Labs focuses on creating immersive experiences that allow consumers to connect more intimately with their favorite brands, fostering vibrant communities and enabling fans to actively participate in content creation. Its innovative approach offers users secure ownership and new avenues for digital interaction, positioning Dapper Labs as a leader in the intersection of entertainment and blockchain technology.

Dapper Labs Inc., founded in 2018 and based in Vancouver, Canada, specializes in developing blockchain-based gaming platforms and collectibles. The company is best known for NBA Top Shot, which utilizes blockchain technology to facilitate non-fungible tokens (NFTs) and enhance digital engagement for sports fans. Dapper Labs focuses on creating immersive experiences that allow consumers to connect more intimately with their favorite brands, fostering vibrant communities and enabling fans to actively participate in content creation. Its innovative approach offers users secure ownership and new avenues for digital interaction, positioning Dapper Labs as a leader in the intersection of entertainment and blockchain technology.

Act-On Software, Inc. is a developer of a cloud-based marketing automation platform tailored for small and mid-sized businesses. The platform enables marketers to create and manage various marketing campaigns, including email marketing, website lead generation, social media marketing, and account-based marketing. Act-On's solutions help organizations attract prospects, convert leads, and measure campaign effectiveness while enhancing customer engagement and brand awareness. Additionally, the company offers professional consulting, support, and training services to optimize the use of its platform. Act-On serves diverse industries such as banking, insurance, manufacturing, technology, and agencies. Founded in 2006 and headquartered in Portland, Oregon, Act-On also has locations in Scottsdale, Arizona, and Reading, United Kingdom.

Neuros Medical, Inc. is a neuromodulation company dedicated to developing innovative therapies to address unmet medical needs for patients globally. Founded in 2008 and headquartered in Willoughby Hills, Ohio, the company specializes in its proprietary platform technology known as Electrical Nerve Block. This technology is designed to eliminate chronic pain across various conditions, including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine. The Neuros Altius System, one of its key products, includes an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices, further demonstrating the company's commitment to advancing pain management solutions.

Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

Edgewise Therapeutics, founded in 2017 and based in Boulder, Colorado, is a clinical-stage biopharmaceutical company dedicated to developing precision medicine therapies for severe, rare muscle disorders. The company's core expertise lies in muscle biology and small molecule engineering, which it employs through its proprietary drug discovery platform. This platform uses custom-built systems to measure integrated muscle function, enabling the identification of small molecule therapies targeting key proteins in muscle tissue. Edgewise's pipeline focuses on addressing genetically defined muscle disorders such as Duchenne muscular dystrophy, Becker muscular dystrophy, and limb-girdle muscular dystrophies.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Stensul is an innovative company focused on transforming email marketing for enterprise-level organizations. Its email generation platform is designed to streamline the email creation process by centralizing and pre-configuring templates to align with each brand's specific requirements. By eliminating the need for extensive collaboration with designers, developers, and quality assurance teams, Stensul allows marketers to concentrate on creating impactful content that drives results. The platform simplifies complex coding and design tasks, enabling marketing teams to produce mobile-responsive emails that adhere to brand, design, and legal standards. As a result, enterprises can efficiently generate effective emails while significantly reducing production time and costs.

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, specializing in the development of tissue-targeted therapeutics aimed at treating cancer, chronic viral infections, and other serious diseases. The company’s lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial and is designed as a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, targeting tumors such as breast and non-small cell lung cancers. Silverback is also advancing SBT6290, a preclinical candidate targeting Nectin4 in various cancers, and SBT8230, which aims to treat chronic hepatitis B virus infection. The company employs its proprietary ImmunoTAC technology platform to create therapies that can be systemically administered while acting specifically at disease sites, thereby potentially modulating fundamental disease pathways previously considered inaccessible. Founded in 2016, Silverback Therapeutics is committed to innovative approaches in biopharmaceutical development.

Medigate by Claroty is a developer of a medical device security platform that safeguards healthcare provider networks from cyber threats. Founded in 2017, the company is headquartered in New York City and focuses on protecting all connected medical devices within these networks. Its platform utilizes deep packet inspection to decode proprietary healthcare IoT protocols, providing visibility and security for IoT and medical devices. By offering threat detection and attack prevention services, Medigate enhances the safety and privacy of hospital environments, allowing for the secure deployment of both existing and new medical devices.

Optimize Health is a provider of a digital healthcare platform focused on enabling Remote Patient Monitoring (RPM) programs. The company offers user-friendly equipment and software designed to support healthcare providers in managing patient care efficiently. Its platform automatically tracks medication doses and sends reminders to patients, ensuring adherence to treatment plans by syncing with smartphones or tablets. This system not only enhances patient engagement but also assists providers in complying with billing requirements for new Medicare codes, promoting profitability for physicians from the outset. Through its innovative approach, Optimize Health aims to improve health outcomes and streamline the management of chronic conditions.

Carrot Fertility, Inc. offers comprehensive fertility benefits services for employers, supporting employees throughout their fertility healthcare journey on a global scale. Founded in 2015 and headquartered in San Francisco, California, the company provides a range of services including egg freezing, in vitro fertilization, adoption, donor and gestational carrier services. It also features Carrot Rx, a premium pharmacy experience for fertility medications, and Carrot Pregnancy, which offers virtual access to experts and on-demand doctor-approved content. Additionally, Carrot Card is a flexible debit card that employees can use to pay for fertility care. Carrot Fertility aims to help companies customize their fertility benefits, ensuring that employees receive the necessary financial, medical, and emotional support as they pursue parenthood. The company has expanded its presence with additional offices in major cities including Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Okami Medical, Inc. is a medical device manufacturer based in Aliso Viejo, California, specializing in the occlusion of peripheral vessels to treat cardiovascular disease. The company's flagship product, the LOw-profile Braided Occluder (LOBO), is designed to provide interventional physicians with a single, versatile device for occluding various arterial targets without the need for multiple embolic devices. The LOBO system features a patented design and proprietary HDBRAID technology, which creates a highly occlusive pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011, Okami Medical aims to meet the evolving needs of patients and healthcare providers by offering innovative solutions that ensure rapid and reliable vessel occlusion, regardless of anatomical challenges.

Zerto is a company that specializes in providing enterprise-class disaster recovery and business continuity software solutions. Founded in 2009 and headquartered in Boston, Massachusetts with additional offices globally, Zerto focuses on keeping IT infrastructure running continuously for both enterprises and cloud environments. Its flagship product, Zerto Virtual Replication, enables the protection, recovery, and migration of applications across various cloud and virtualized data centers. The company's BC/DR Platform offers disaster recovery as a service for public, private, and hybrid clouds, catering to industries such as healthcare, legal, and financial services.

Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed to enhance enterprise connectivity and security. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations including San Jose, California, and London, the company offers an integrated solution that combines software-defined wide area networking (SD-WAN) with advanced security features. This platform enables organizations to securely connect all their locations, users, and data while optimizing application access and performance. Cato Networks helps businesses reduce costs associated with traditional MPLS connections, improves overall performance for global locations and cloud applications, and simplifies network management through its cloud-native service. Its offerings include WAN optimization, firewall protection, secure web gateway, and secure remote access, making it suitable for distributed, mobile, and cloud-enabled enterprises.

Forager Logistics LLC, established in 2018 and based in Chicago, Illinois, specializes in freight brokerage and logistics services for the automotive and aerospace industries. The company offers a range of truckload services, including standard, expedited, and cross-border transportation, catering to supply chain networks with seamless and modern solutions. Forager's innovative web-based transportation management platform further enhances its service, targeting the complexities of cross-border shipping, particularly to and from Mexico and Canada.

Arkose Labs, Inc. is a cybersecurity company that specializes in online fraud and abuse prevention for various sectors, including online marketplaces, banking, and gaming. Founded in 2015 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, the company provides a platform aimed at protecting consumers from threats such as account takeover, fake accounts, and spam. Arkose Labs employs an AI-powered system that integrates risk assessments with dynamic threat response, enabling businesses to efficiently combat fraud while maintaining a seamless user experience. The company has gained recognition for its innovative solutions, including offering substantial warranties against credential stuffing and SMS toll fraud. With a significant portion of its clientele comprising Fortune 500 companies, Arkose Labs is focused on creating a secure online environment by simplifying identity authentication and mitigating cyber threats.

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, specializing in the development of tissue-targeted therapeutics aimed at treating cancer, chronic viral infections, and other serious diseases. The company’s lead product candidate, SBT6050, is currently in a Phase I/Ib clinical trial and is designed as a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody, targeting tumors such as breast and non-small cell lung cancers. Silverback is also advancing SBT6290, a preclinical candidate targeting Nectin4 in various cancers, and SBT8230, which aims to treat chronic hepatitis B virus infection. The company employs its proprietary ImmunoTAC technology platform to create therapies that can be systemically administered while acting specifically at disease sites, thereby potentially modulating fundamental disease pathways previously considered inaccessible. Founded in 2016, Silverback Therapeutics is committed to innovative approaches in biopharmaceutical development.

HealthJoy, LLC is a healthcare decision platform based in Chicago, Illinois, founded in 2014. The company operates a benefits experience platform designed to simplify the healthcare process for employees and improve their understanding of available benefits. By leveraging personalized guidance and artificial intelligence, HealthJoy empowers users to make informed healthcare decisions, helping them reduce out-of-pocket expenses. The platform offers a digital benefits wallet that integrates with existing employer benefits, providing on-demand access to online medical consultations, healthcare concierges, prescription savings, and more. Through its services, HealthJoy aims to create happier, more informed employees while simultaneously supporting companies in cost containment and reducing the volume of inquiries directed to HR.

Epsagon Ltd. is a technology company based in Tel Aviv, Israel, founded in 2017. It specializes in developing solutions for monitoring serverless architecture systems, providing a Software as a Service (SaaS) platform that enhances visibility and troubleshooting capabilities for Dev and Ops teams. Epsagon's platform enables organizations to achieve end-to-end observability in microservice environments by offering automated data correlation, payload analysis, and performance tracking. This comprehensive monitoring allows enterprises to predict and address potential performance issues before they impact operations, thereby reducing application downtime and enhancing engineering efficiency. With a focus on ease of use, Epsagon's lightweight agent SDK facilitates automated instrumentation and tracing without the need for manual coding or maintenance. The company aims to optimize operational costs through scalable pricing and unlimited free monitoring, catering to organizations of all sizes.

ShiraTronics, Inc. is a company focused on developing and commercializing innovative therapies for the treatment of chronic migraines. Incorporated in 2018 and headquartered in Ireland, with an additional location in Minneapolis, Minnesota, ShiraTronics utilizes advanced neuromodulation technology to address the unmet clinical needs of patients suffering from debilitating migraine headaches. The company's mission is to transform the lives of those affected by this widespread and disabling disorder, which impacts millions globally, by providing effective solutions that enhance their quality of life.

Kenna Security, founded in 2009 and headquartered in San Francisco with an additional office in Chicago, is a technology company specializing in vulnerability management and risk intelligence solutions. It offers Kenna, a SaaS platform that helps organizations accurately measure and prioritize cyber risks, enabling cross-functional teams to remediate vulnerabilities effectively. Serving various sectors including finance, healthcare, and energy, Kenna's platform leverages predictive analytics to anticipate real-world exploitations, focusing security efforts on critical areas.

Primary makes clothes for kids and builds a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Edgewise Therapeutics, founded in 2017 and based in Boulder, Colorado, is a clinical-stage biopharmaceutical company dedicated to developing precision medicine therapies for severe, rare muscle disorders. The company's core expertise lies in muscle biology and small molecule engineering, which it employs through its proprietary drug discovery platform. This platform uses custom-built systems to measure integrated muscle function, enabling the identification of small molecule therapies targeting key proteins in muscle tissue. Edgewise's pipeline focuses on addressing genetically defined muscle disorders such as Duchenne muscular dystrophy, Becker muscular dystrophy, and limb-girdle muscular dystrophies.

Luma Health Inc. is a technology company that specializes in developing a patient engagement platform aimed at enhancing communication between healthcare providers and patients. Founded in 2015 and based in San Francisco, California, the company offers a suite of services designed to streamline various aspects of patient care, including smart scheduling, appointment reminders, mobile patient intake, and referral management. Luma Health's platform also integrates with electronic health records (EHR) and provides insights and analytics to improve healthcare delivery. By facilitating better access and communication, Luma Health enables healthcare systems and clinics to optimize appointment scheduling, enhance patient adherence to care plans, and promote continuous care, ultimately improving overall treatment outcomes.

Entelo is a recruitment platform that leverages data science and machine learning to assist companies in identifying and recruiting technical talent. Its SaaS-based solution enables talent acquisition teams to automatically rank and screen applicants using directed scoring technologies, thereby enhancing key metrics such as quality of hire, time to hire, and cost per hire. With over 600 customers across various industries, Entelo provides actionable insights and increases candidate engagement, making it a trusted partner for organizations aiming to improve their recruitment processes. Notable clients include prominent companies like Capital One, Cisco, and Netflix, which utilize Entelo's capabilities to build effective teams.

Rimeto LLC, founded in 2016 and based in San Francisco, California, specializes in developing application and system software that enhances employee directories and profiles. The company focuses on providing customers with detailed, people-centric tools designed to improve collaboration within the workplace. By integrating data from various enterprise systems, Rimeto enables organizations to create custom-built directories that facilitate access to information about people, projects, and teams. This integration allows for the normalization of data from public and proprietary sources, making it easier for users to search and access actionable insights. As a subsidiary of Slack Technologies, Rimeto aims to empower individuals with the resources needed to work effectively and feel connected to their colleagues.

Human Interest is a retirement plan provider based in San Francisco, California, founded in 2015 by Paul Sawaya and Roger Lee. The company specializes in making it easy for small and medium-sized businesses to offer retirement savings plans to their employees. Human Interest has developed an end-to-end technology platform that addresses administrative and compliance challenges, providing affordable and straightforward employee retirement plans. This platform automatically creates employee accounts and syncs deductions with payroll providers, while also offering personalized investment advice. Through these services, Human Interest has assisted thousands of businesses across America in providing retirement accounts to their employees.

Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company focuses on developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By creating enzyme inhibitors designed to disrupt these pathways, Cleave Therapeutics aims to address both oncological and neurodegenerative diseases. Through its innovative approach to drug discovery, the company seeks to provide effective therapeutic solutions that enhance patient outcomes in the fight against cancer.

Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Dstillery, Inc. is a digital intelligence platform based in New York that specializes in developing marketing solutions for brands and media partners. Founded in 2008, the company offers a range of services aimed at enhancing brand awareness, consideration, and customer retention. Dstillery's platform utilizes artificial intelligence to capture mobile location insights and integrate them with desktop behaviors, thereby optimizing advertising across mobile, desktop, and video channels. The company is recognized for its innovative technology, including its patented ID-free® behavioral targeting, which provides privacy-safe ad targeting that reaches all ad impressions. Dstillery also offers Custom AI Audiences, a targeting solution that refreshes user data regularly to ensure optimal campaign performance. The company primarily serves clients within the United States and has earned numerous patents for its advanced technologies that facilitate effective audience engagement and maximize marketing effectiveness.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Happy Returns, Inc. is a company based in Santa Monica, California, that specializes in providing in-person return solutions for online shoppers. Founded in 2015, it operates a network of Return Bars and kiosks that allow customers to return items physically and receive immediate refunds. After the returns are processed, the company manages the logistics of shipping the items back to the respective e-commerce retailers. By offering a seamless integration of technology, service, and logistics, Happy Returns aims to enhance the returns experience for both consumers and retailers, delivering an efficient and cost-effective solution for handling returns in the online shopping landscape.

HealthJoy, LLC is a healthcare decision platform based in Chicago, Illinois, founded in 2014. The company operates a benefits experience platform designed to simplify the healthcare process for employees and improve their understanding of available benefits. By leveraging personalized guidance and artificial intelligence, HealthJoy empowers users to make informed healthcare decisions, helping them reduce out-of-pocket expenses. The platform offers a digital benefits wallet that integrates with existing employer benefits, providing on-demand access to online medical consultations, healthcare concierges, prescription savings, and more. Through its services, HealthJoy aims to create happier, more informed employees while simultaneously supporting companies in cost containment and reducing the volume of inquiries directed to HR.

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed to enhance enterprise connectivity and security. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations including San Jose, California, and London, the company offers an integrated solution that combines software-defined wide area networking (SD-WAN) with advanced security features. This platform enables organizations to securely connect all their locations, users, and data while optimizing application access and performance. Cato Networks helps businesses reduce costs associated with traditional MPLS connections, improves overall performance for global locations and cloud applications, and simplifies network management through its cloud-native service. Its offerings include WAN optimization, firewall protection, secure web gateway, and secure remote access, making it suitable for distributed, mobile, and cloud-enabled enterprises.

Medigate by Claroty is a developer of a medical device security platform that safeguards healthcare provider networks from cyber threats. Founded in 2017, the company is headquartered in New York City and focuses on protecting all connected medical devices within these networks. Its platform utilizes deep packet inspection to decode proprietary healthcare IoT protocols, providing visibility and security for IoT and medical devices. By offering threat detection and attack prevention services, Medigate enhances the safety and privacy of hospital environments, allowing for the secure deployment of both existing and new medical devices.

HighLife is a medical technology company specializing in Transcatheter Mitral Valve Replacement (TMVR) aimed at treating mitral valve regurgitation. Founded in 2010 by Georg Börtlein, the company is developing a minimally invasive prosthetic mitral valve designed to be implanted on a beating heart, allowing for the preservation of the native valve structure and surrounding anatomy. HighLife's innovative system facilitates a transseptal delivery through the femoral vein, enabling a reversible approach that minimizes trauma to patients during surgical procedures. The technology is currently undergoing clinical evaluation, with a focus on ensuring ease and safety of use for healthcare providers.

Ribon Therapeutics, Inc. is a biotechnology company founded in 2015 and headquartered in Lexington, Massachusetts. The company focuses on developing novel therapeutics that target monoPARP proteins, which are critical regulators of cancer cell survival mechanisms. By leveraging insights from its scientific founders, Ribon is establishing a proprietary drug discovery platform aimed at investigating the molecular actions and biological functions of a specific subset of the PARP protein family. This platform enables Ribon to create a pipeline of innovative small molecule inhibitors designed to disrupt the fundamental survival capabilities of cancer cells under stress. In addition to cancer treatment, the company's research may have implications for addressing other diseases. Ribon is supported by notable life science investors, which enhances its capacity to advance its therapeutic developments.

NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, specializing in innovative solutions for degenerative mitral valve disease (DMR). Founded in 2007, the company has developed the NeoChord Artificial Chordae Delivery System, a proprietary device that enables mitral valve repair to be performed while the heart is still beating. This minimally invasive technique involves a small incision, significantly reducing recovery time and complications compared to traditional procedures that require larger chest incisions and stopping the heart. NeoChord's system addresses severe mitral regurgitation caused by elongated or ruptured chordae tendineae, allowing surgeons to effectively manage blood flow without the need for cardiopulmonary bypass.

ZypMedia, Inc., also known as ZypTV, operates a demand-side platform that facilitates connections between advertisers and audiences on streaming television. Established in 2013 and headquartered in San Francisco, California, with additional offices in New York City, New Delhi, and Saint Petersburg, ZypMedia provides products such as ZypTV Enterprise and ZypTV Self-Serve, which cater to local streaming TV advertising. The company serves local media companies, media buying agencies, and brands aiming to reach local audiences at scale. By leveraging machine learning alongside human expertise, ZypMedia offers a comprehensive digital advertising technology platform designed to enhance local-focused advertising efforts. Its innovative tools help clients bridge the gap between traditional and digital media, enabling them to expand their reach and increase revenue in a rapidly changing media landscape.

Arkose Labs, Inc. is a cybersecurity company that specializes in online fraud and abuse prevention for various sectors, including online marketplaces, banking, and gaming. Founded in 2015 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, the company provides a platform aimed at protecting consumers from threats such as account takeover, fake accounts, and spam. Arkose Labs employs an AI-powered system that integrates risk assessments with dynamic threat response, enabling businesses to efficiently combat fraud while maintaining a seamless user experience. The company has gained recognition for its innovative solutions, including offering substantial warranties against credential stuffing and SMS toll fraud. With a significant portion of its clientele comprising Fortune 500 companies, Arkose Labs is focused on creating a secure online environment by simplifying identity authentication and mitigating cyber threats.

Raken, Inc. is a developer of construction management software that enhances field and office applications within the construction industry. Founded in 2012 and based in Carlsbad, California, Raken offers a mobile-first platform that streamlines workflows for general and trade contractors, including those in the concrete, electrical, excavating, and mechanical sectors. Its software facilitates daily reporting, time card management, production tracking, toolbox talks, photo management, and more, allowing users to efficiently document and manage a range of construction-related tasks such as site safety, weather conditions, and equipment rental. Raken's solution connects field operations to office management, enabling professionals like superintendents and project managers to quickly record and submit essential documentation.

Luma Health Inc. is a technology company that specializes in developing a patient engagement platform aimed at enhancing communication between healthcare providers and patients. Founded in 2015 and based in San Francisco, California, the company offers a suite of services designed to streamline various aspects of patient care, including smart scheduling, appointment reminders, mobile patient intake, and referral management. Luma Health's platform also integrates with electronic health records (EHR) and provides insights and analytics to improve healthcare delivery. By facilitating better access and communication, Luma Health enables healthcare systems and clinics to optimize appointment scheduling, enhance patient adherence to care plans, and promote continuous care, ultimately improving overall treatment outcomes.

Inari Medical, Inc. is a commercial-stage medical device company based in Irvine, California, that specializes in developing innovative products for the treatment of venous diseases. Founded in 2011, the company's primary focus is on venous thromboembolism, which it addresses through two key devices: the ClotTriever and the FlowTriever. The ClotTriever is designed for the minimally invasive removal of blood clots from peripheral blood vessels, specifically targeting patients with deep vein thrombosis. Meanwhile, the FlowTriever system effectively treats pulmonary embolism by removing large clots from major blood vessels without the need for thrombolytic drugs. Inari Medical primarily generates its revenue from the United States while also reaching international markets.